These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 26138237

  • 1. Diagnosis, etiology and management of the Budd-Chiari Syndrome: a bloodcoagulation and hepatological study on the course of the disease treated with TIPS.
    Dulíček P, Hůlek P, Krajina A, Renc O, Šafka V, Fejfar T, Sadílek P, Beránek M, Michiels JJ, Žák P.
    Int Angiol; 2016 Feb; 35(1):90-7. PubMed ID: 26138237
    [Abstract] [Full Text] [Related]

  • 2. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
    Hernández-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, García-Pagán JC.
    Hepatology; 2004 Nov; 40(5):1197-202. PubMed ID: 15486923
    [Abstract] [Full Text] [Related]

  • 3. [Budd-Chiari syndrome and TIPS--twelve years' experience].
    Safka V, Hůlek P, Krajina A, Dulícek P, Fejfar T, Jirkovský V, Pozler O, Vańásek T.
    Cas Lek Cesk; 2005 Nov; 144 Suppl 3():38-42. PubMed ID: 16335262
    [Abstract] [Full Text] [Related]

  • 4. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.
    Gandini R, Konda D, Simonetti G.
    Radiology; 2006 Oct; 241(1):298-305. PubMed ID: 16908675
    [Abstract] [Full Text] [Related]

  • 5. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
    Opitz T, Buchwald AB, Lorf T, Awuah D, Ramadori G, Nolte W.
    Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
    [Abstract] [Full Text] [Related]

  • 6. Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
    Valla DC.
    Hepatol Int; 2018 Feb; 12(Suppl 1):168-180. PubMed ID: 28685257
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I, Kelekis DA, Karatza C, Nikolaou V, Mouyia V, Brountzos EN.
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [Abstract] [Full Text] [Related]

  • 8. Primary Budd-Chiari syndrome - a single center experience.
    Raszeja-Wyszomirska J, Mieżyńska-Kurtycz J, Marlicz W, Lawniczak M, Wójcicki M.
    Hepatogastroenterology; 2012 Sep; 59(118):1879-82. PubMed ID: 22819909
    [Abstract] [Full Text] [Related]

  • 9. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center.
    Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E.
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):691-7. PubMed ID: 23860938
    [Abstract] [Full Text] [Related]

  • 10. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
    Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA.
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
    [Abstract] [Full Text] [Related]

  • 11. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.
    He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ.
    World J Gastroenterol; 2015 Feb 28; 21(8):2413-8. PubMed ID: 25741149
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
    Darwish Murad S, Luong TK, Pattynama PM, Hansen BE, van Buuren HR, Janssen HL.
    Liver Int; 2008 Feb 28; 28(2):249-56. PubMed ID: 18251982
    [Abstract] [Full Text] [Related]

  • 13. Budd-Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome.
    Kathuria R, Srivastava A, Yachha SK, Poddar U, Baijal SS.
    Eur J Gastroenterol Hepatol; 2014 Sep 28; 26(9):1030-8. PubMed ID: 25003745
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome.
    Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK.
    Eur J Gastroenterol Hepatol; 2017 Oct 28; 29(10):1174-1182. PubMed ID: 28763339
    [Abstract] [Full Text] [Related]

  • 15. Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome.
    Mo A, Testro A, French J, Robertson M, Angus P, Grigg A.
    Intern Med J; 2017 Dec 28; 47(12):1361-1367. PubMed ID: 28675622
    [Abstract] [Full Text] [Related]

  • 16. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome.
    Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V.
    Radiology; 2017 Apr 28; 283(1):280-292. PubMed ID: 27797679
    [Abstract] [Full Text] [Related]

  • 17. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study.
    Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A.
    World J Gastroenterol; 2017 Jan 28; 23(4):629-637. PubMed ID: 28216969
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Budd-Chiari syndrome with transjugular intrahepatic portosystemic shunt (TIPS).
    Corso R, Intotero M, Solcia M, Castoldi MC, Rampoldi A.
    Radiol Med; 2008 Aug 28; 113(5):727-38. PubMed ID: 18618075
    [Abstract] [Full Text] [Related]

  • 19. Etiology, management, and outcome of the Budd-Chiari syndrome.
    Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL, EN-Vie (European Network for Vascular Disorders of the Liver).
    Ann Intern Med; 2009 Aug 04; 151(3):167-75. PubMed ID: 19652186
    [Abstract] [Full Text] [Related]

  • 20. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.
    Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E.
    Gut; 2006 Jun 04; 55(6):878-84. PubMed ID: 16174658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.